2024 年口服给药系统全球市场报告

近年来，口服给药系统的市场规模迅速扩大。将从2023年的32.8亿美元成长到2024年的36.4亿美元，复合年增长率为11.0%。业绩期间的成长是由药物输送的早期创新、製药业的采用、证明疗效的临床研究、市场渗透策略和特异性疾病的应用所推动的。

从事口服给药系统市场的公司正专注于推出其产品以产生收益。一个着名的例子是 Arlak Biotech Private Limited 推出的褪黑激素口腔喷雾剂。褪黑激素口腔喷雾剂提供了一种简单有效的方法来促进体内褪黑激素的自​​然产生并改善您的睡眠品质。这些产品类型满足特定的医疗需求，并有助于口服给药系统市场的成长。

2023年，北美是口服给药系统市场占有率最大的地区。口服给药系统市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

• 高通膨对市场的影响
• 乌克兰与俄罗斯战争对市场的影响
• COVID-19 对市场的影响

第五章世界市场规模与成长

• 全球口服给药系统市场的驱动与限制因素
  • 市场驱动因素
  • 市场限制因素
• 2018-2023年全球口服给药系统市场规模表现及成长
• 2023-2028、2033年全球口服给药系统市场规模及成长预测

第六章市场区隔

• 全球口服给药系统市场，依类型、实际及预测细分，2018-2023、2023-2028、2033
• 舌下
• 口服片剂和锭剂
• 口腔喷雾剂
• 全球口服给药系统市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
• 疼痛管理
• 禁止抽烟
• 心绞痛
• 全球口服给药系统市场，依最终使用者细分，实际与预测，2018-2023、2023-2028、2033
• 医院
• 门诊中心
• 其他的

第 7 章 区域与国家分析

• 全球口服给药系统市场，按地区、绩效及预测，2018-2023、2023-2028、2033
• 全球口服给药系统市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

• 口服给药系统市场竞争形势
• 口服给药系统市场公司概况
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer Incorporated
  • GlaxoSmithKline Public Limited Company
  • Indivior plc
  • Generex Biotechnology Corporation

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与潜力分析

第35章附录

Buccal Drug Delivery System Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Sublingual; Buccal Tablets and Lozenges; Oral Sprays
• 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
• 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
• Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.28 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to early innovations in drug delivery, the adoption by the pharmaceutical industry, clinical studies demonstrating efficacy, market penetration strategies, and disease-specific applications.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to patient-centric drug delivery, the rising geriatric population, demand for targeted therapies, delivery of biologics and peptides, regulatory support and approvals, and investments in research and development. Major trends in the forecast period include a focus on patient convenience and compliance, advancements in drug formulations, an increase in chronic diseases, attention to pediatric and geriatric care, and enhanced bioavailability.

The buccal drug delivery systems market is expected to experience growth due to the rising prevalence of chronic diseases. Chronic diseases, such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, persist for an extended period and require continuous medical care. The World Health Organization reported that 74% of the 41 million global deaths annually are caused by non-communicable diseases (NCDs) or chronic diseases. Buccal drug delivery systems provide an effective means of administering mucosal and transmucosal drugs, making them suitable for patients with chronic conditions. This increasing prevalence of chronic diseases contributes to the growth of the buccal drug delivery systems market.

The buccal drug delivery systems market is expected to be propelled by the increasing demand in hospitals. Hospitals, as specialized facilities for medical treatment and care, have a growing need for buccal drug delivery systems. These systems offer advantages such as rapid drug absorption, improved patient compliance, reduced gastrointestinal side effects, and controlled drug release. According to the American Hospital Association, the total number of hospitals in the United States increased to 6,129 in comparison to 6,093 in the previous year. The rising number of hospital admissions further supports the demand for buccal drug delivery systems, driving market growth.

Investments in injectable drug delivery systems emerge as a key trend in the buccal drug delivery systems market. Major pharmaceutical companies, such as Novartis, are making significant investments in innovative drug delivery systems. Novartis invested approximately $40 million in Credence MedSystems, a company focused on developing innovative drug delivery systems. This trend reflects a broader industry focus on advancing drug delivery technologies to improve patient outcomes and enhance treatment effectiveness.

Companies operating in the buccal drug delivery systems market are focusing on product launches to drive revenues. One notable example is the launch of melatonin oral spray by Arlak Biotech Private Limited. Melatonin oral spray provides an easy and effective way to facilitate the body's natural production of melatonin, aiding in improving sleep quality. This type of product launch addresses specific healthcare needs, contributing to the growth of the buccal drug delivery systems market.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. This strategic acquisition aimed to enhance DifGen's research and development (R&D) and manufacturing capabilities, ensuring a secure supply of high-quality and cost-effective medications. Aveva Drug Delivery Services Inc. specializes in buccal drug delivery systems, aligning with DifGen's goal of providing advanced and reliable pharmaceutical solutions.

Major companies operating in the buccal drug delivery system market report are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., and Opiant Pharmaceuticals Inc.

North America was the largest region in the buccal drug delivery systems market share in 2023. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Buccal Drug Delivery System Market Characteristics

3. Buccal Drug Delivery System Market Trends And Strategies

4. Buccal Drug Delivery System Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Buccal Drug Delivery System Market Size and Growth

• 5.1. Global Buccal Drug Delivery System Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Buccal Drug Delivery System Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Buccal Drug Delivery System Market Segmentation

• 6.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Sublingual
• Buccal Tablets and Lozenges
• Oral Sprays
• 6.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pain Management
• Smoking Cesstion
• Angina Pectoris
• 6.3. Global Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Centers
• Other End-Users

7. Buccal Drug Delivery System Market Regional And Country Analysis

• 7.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Buccal Drug Delivery System Market

• 8.1. Asia-Pacific Buccal Drug Delivery System Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Buccal Drug Delivery System Market

• 9.1. China Buccal Drug Delivery System Market Overview
• 9.2. China Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Buccal Drug Delivery System Market

• 10.1. India Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Buccal Drug Delivery System Market

• 11.1. Japan Buccal Drug Delivery System Market Overview
• 11.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Buccal Drug Delivery System Market

• 12.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Buccal Drug Delivery System Market

• 13.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Buccal Drug Delivery System Market

• 14.1. South Korea Buccal Drug Delivery System Market Overview
• 14.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Buccal Drug Delivery System Market

• 15.1. Western Europe Buccal Drug Delivery System Market Overview
• 15.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Buccal Drug Delivery System Market

• 16.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Buccal Drug Delivery System Market

• 17.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Buccal Drug Delivery System Market

• 18.1. France Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Buccal Drug Delivery System Market

• 19.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Buccal Drug Delivery System Market

• 20.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Buccal Drug Delivery System Market

• 21.1. Eastern Europe Buccal Drug Delivery System Market Overview
• 21.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Buccal Drug Delivery System Market

• 22.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Buccal Drug Delivery System Market

• 23.1. North America Buccal Drug Delivery System Market Overview
• 23.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Buccal Drug Delivery System Market

• 24.1. USA Buccal Drug Delivery System Market Overview
• 24.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Buccal Drug Delivery System Market

• 25.1. Canada Buccal Drug Delivery System Market Overview
• 25.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Buccal Drug Delivery System Market

• 26.1. South America Buccal Drug Delivery System Market Overview
• 26.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Buccal Drug Delivery System Market

• 27.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Buccal Drug Delivery System Market

• 28.1. Middle East Buccal Drug Delivery System Market Overview
• 28.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Buccal Drug Delivery System Market

• 29.1. Africa Buccal Drug Delivery System Market Overview
• 29.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Buccal Drug Delivery System Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

• 30.1. Buccal Drug Delivery System Market Competitive Landscape
• 30.2. Buccal Drug Delivery System Market Company Profiles
  • 30.2.1. Teva Pharmaceuticals Industries Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Incorporated
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GlaxoSmithKline Public Limited Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Indivior plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Generex Biotechnology Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Buccal Drug Delivery System Market Competitive Benchmarking

32. Global Buccal Drug Delivery System Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

34. Buccal Drug Delivery System Market Future Outlook and Potential Analysis

• 34.1 Buccal Drug Delivery System Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Buccal Drug Delivery System Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Buccal Drug Delivery System Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer